Anavex Life Sciences Corp (AVXL)

[Steady_T]

Australia hasn't done anything for Anavex that it doesn't do for other companies that are running trials in AU.

It doesn't hurt that many of the sites for the AD and Rett trials are in AU and that might confer a small advantage when the TGA evaluates Anavex's drug application because the population does represent the AU population to a greater degree than say the US or Spain.

The TGA will evaluate 2-73 on the data presented. It's a safe bet that the politicians will point to the 2-73 success as a positive result for the trial reimbursement program. That's what politicians do.